DJIA 17,086.63 -26.91 -0.16%
NASDAQ 4,473.70 17.68 0.40%
S&P 500 1,987.01 3.48 0.18%
market minute promo

Repligen Corp (NASDAQ: RGEN)

23.68 0.19 (0.81%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

RGEN $23.68 0.81%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $23.48
Previous Close $23.49
Daily Range $23.20 - $23.98
52-Week Range $9.41 - $24.68
Market Cap $758.7M
P/E Ratio 41.95
Dividend (Yield) $0.00 (0.0%)
Volume 240,655
Average Daily Volume 477,605
Current FY EPS $0.29





Repligen Corp (RGEN) Description

A biopharmaceutical company focused on the development of novel therapeutics for the treatment of diseases of the central nervous system. Website:

News & Commentary

This Week in Biotech: Clinical Success, Plus Wheeling and Dealing

Two positive clinical results, a symbiotic asset deal, and a rumored takeover target are this week's top stories in Part 2 of "This Week in Biotech."

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Repligen (RGEN) Shares March Higher, Can It Continue? - Tale of the Tape

Stocks Hitting 52-Week Highs

XBI, MNKD, MACK, RGEN: ETF Outflow Alert

SPDR S&P Biotech ETF Experiences Big Outflow

Surges In Biotech Short Interest (INCY, PCYC, RGEN)

Sector Update: Healthcare Shares Mixed Pre-Market; Repligen's Earnings Nearly Double Estimates

Sector Update: Healthcare

Repligen: A Strong Investment For The Right Kind Of Investor

Noteworthy ETF Outflows: XBI, SRPT, MNKD, RGEN

RGEN: Insiders Vs. Shorts

See More RGEN News...

RGEN's Top Competitors

RGEN $23.68 (0.81%)
Current stock: RGEN
GILD $90.34 (1.13%)
Current stock: GILD
BIIB $337.60 (11.17%)
Current stock: BIIB
CELG $89.12 (2.84%)
Current stock: CELG